Creative Medical Technology Holdings, Inc. Finite-Lived Patents, Gross
Creative Medical Technology Holdings, Inc. (CELZ) had Finite-Lived Patents, Gross of $300.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2026-08-07
- 2026-06-30: Finite-Lived Patents, Gross $300.00K.
- 2026-03-31: Finite-Lived Patents, Gross $300.00K.
- 2025-12-31: Finite-Lived Patents, Gross $300.00K.
- 2025-09-30: Finite-Lived Patents, Gross $300.00K.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $300.00K 10-K · filed 2026-03-20 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |